Lupus
Hair loss in systemic lupus may indicate active disease
Scarcity of lupus assays in developing countries limit utility of international criteria, trials
ATLANTA — Limited access to supportive laboratory assays in developing countries significantly reduces the diagnostic utility of the ACR/EULAR criteria for systemic lupus erythematosus, which relies on an antinuclear antibody titer of 1:80 for its entry criterion, noted a presenter at the 2019 ACR/ARP Annual Meeting.
TULIP-1: Anifrolumab fails primary endpoint, confers clinical benefit in SLE
Lupus algorithm, pediatric psoriasis guidelines lead dermatology news
Study finds pathway for UVB light exposure as trigger for flares in SLE
Lupus Foundation of America encourages patient self-management
Experts create algorithm for management of cutaneous manifestations in lupus
Pain, fatigue topped list of symptoms most important to patients with rheumatic disease
Any smoking exposure in patients with lupus affects cutaneous manifestations
Researchers suggested there is a dose relationship between smoking exposure and cutaneous manifestations in systemic lupus erythematosus, which highlights the importance of smoking cessation to improve outcomes, according to a presentation at the American College of Rheumatology/Association of Rheumatology Professionals annual meeting.